1832 Asset Management
PFE icon

1832 Asset Management’s Pfizer PFE Stock Holding History

1832 Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-380,000
Closed -$16.6M – 952
2022
Q3 		$16.6M Hold
380,000
– – 0.03% 295
2022
Q2 		$19.9M Hold
380,000
– – 0.03% 274
2022
Q1 		$19.7M Buy
+380,000
New +$19.7M 0.03% 312

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

1832 Asset Management's PFE Position: Q1 2026 in Review

1832 Asset Management increased its Pfizer (PFE) stake by 0.4% in Q1 2026, buying an estimated $28.4K and bringing the position to 265,437 shares worth $7.45M. The position accounts for 0.01% of the portfolio, ranked #391.

1832 Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $649M in Q4 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • 1832 Asset Management held 265,437 shares of Pfizer worth $7.45M as of Q1 2026.
  • 1832 Asset Management bought 1,067 Pfizer shares in Q1 2026, an estimated $28.4K.
  • Pfizer made up 0.01% of 1832 Asset Management's portfolio in Q1 2026, its #391 holding.
  • 1832 Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 1832 Asset Management's Pfizer position peaked at $649M in Q4 2016.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.